Glenmark forms JV with True North for pain management, orthopaedic business

The business is valued at Rs 6.35 bn and Glenmark will continue to hold a stake in the new company

drugs, medicines, USFDA
Aneesh Phadnis Mumbai
Last Updated : Aug 10 2018 | 10:36 PM IST
Glenmark has formed a joint venture with private equity firm True North for its pain management and orthopaedic products business in India and Nepal.

The business is valued at Rs 6.35 billion and Glenmark will continue to hold a stake in the new company along with True North. Specific shareholding details were not disclosed. 

The business earned Rs 1.55 billion in revenue in the last financial year and accounted for six per cent of Glenmark's India sales and 1.7 per cent of its consolidated revenue during the same period. 

Sujesh Vasudevan, who heads Glenmark's India formulations business, will join the board of the new entity, which will house two businesses. "Glenmark is present in multiple therapy areas in India and remains committed to grow each of the business segments. With a view to provide additional focus and resources to the orthopaedic franchise, we are collaborating with True North and firmly believe that this alliance will help unleash full potential of this business," Vasudevan said in a statement.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story